NDC 62856-529

Belviq

Lorcaserin Hydrochloride Hemihydrate

Belviq is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Eisai Inc.. The primary component is Lorcaserin Hydrochloride Hemihydrate.

Product ID62856-529_3097271d-6dae-4dce-91c2-783e31678eb6
NDC62856-529
Product TypeHuman Prescription Drug
Proprietary NameBelviq
Generic NameLorcaserin Hydrochloride Hemihydrate
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2012-06-27
Marketing CategoryNDA / NDA
Application NumberNDA022529
Labeler NameEisai Inc.
Substance NameLORCASERIN HYDROCHLORIDE HEMIHYDRATE
Active Ingredient Strength10 mg/1
Pharm ClassesSerotonin-2c Receptor Agonist [EPC],Serotonin 2c Receptor Agonists [MoA],Cytochrome P450 2D6 Inhibitors [MoA]
DEA ScheduleCIV
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 62856-529-60

60 TABLET in 1 BOTTLE (62856-529-60)
Marketing Start Date2012-06-27
Marketing End Date2022-04-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 62856-529-60 [62856052960]

Belviq TABLET
Marketing CategoryNDA
Application NumberNDA022529
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-06-27

Drug Details

Active Ingredients

IngredientStrength
LORCASERIN HYDROCHLORIDE HEMIHYDRATE10 mg/1

OpenFDA Data

SPL SET ID:7cbbb12f-760d-487d-b789-ae2d52a3e01f
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1300712
  • 1808552
  • 1808549
  • 1300706
  • UPC Code
  • 0362856529600
  • 0362856535304
  • Pharmacological Class

    • Serotonin-2c Receptor Agonist [EPC]
    • Serotonin 2c Receptor Agonists [MoA]
    • Cytochrome P450 2D6 Inhibitors [MoA]

    Medicade Reported Pricing

    62856052960 BELVIQ 10 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Belviq" or generic name "Lorcaserin Hydrochloride Hemihydrate"

    NDCBrand NameGeneric Name
    62856-529Belviqlorcaserin hydrochloride hemihydrate
    62856-535BELVIQ XRlorcaserin hydrochloride hemihydrate

    Trademark Results [Belviq]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    BELVIQ
    BELVIQ
    85962041 4550429 Live/Registered
    Arena Pharmaceuticals GmbH
    2013-06-17
    BELVIQ
    BELVIQ
    85714025 4599551 Live/Registered
    EISAI INC.
    2012-08-27
    BELVIQ
    BELVIQ
    85714013 4415887 Live/Registered
    EISAI INC.
    2012-08-27
    BELVIQ
    BELVIQ
    85660690 4415734 Live/Registered
    EISAI INC.
    2012-06-25
    BELVIQ
    BELVIQ
    85660637 4639221 Live/Registered
    Arena Pharmaceuticals GmbH
    2012-06-25
    BELVIQ
    BELVIQ
    85660483 4599534 Live/Registered
    EISAI INC.
    2012-06-25
    BELVIQ
    BELVIQ
    85354490 4080253 Live/Registered
    EISAI INC.
    2011-06-23

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.